### ü´Å Critical Care Medicine: Postextubation Noninvasive Ventilation in COPD

#### ‚úÖ True Statements
1. **Noninvasive positive-pressure ventilation (NIPPV)** with **bilevel positive airway pressure (BPAP)** immediately after extubation prevents **extubation failure** in patients at high risk with **chronic obstructive pulmonary disease (COPD) exacerbation**, **hypercapnia**, or **heart failure**.
2. Patients with **chronic obstructive pulmonary disease (COPD)** considered at risk for **recurrent respiratory failure** should receive **BPAP immediately after extubation**, with subsequent weaning over several days as clinical progress allows.
3. In patients with **obesity hypoventilation syndrome** and **apnea**, **BPAP in spontaneous/timed (S/T) mode** with a minimum respiration rate may provide additional benefit.
4. **Tracheostomy** is indicated if the need for **mechanical ventilation** is anticipated to be more than **3 weeks**, not for patients otherwise ready for extubation with BPAP support.
5. The role of **excessive fraction of inspired oxygen (FiO‚ÇÇ)** in reducing hypoxic ventilatory drive is often **overemphasized** in **COPD exacerbation**, and an oxygen saturation in the acceptable range does not contribute to apnea.
6. **Noninvasive positive-pressure ventilation with BPAP** is useful in facilitating **early extubation** of patients with **COPD**.

#### üí¨ Extra
1. Evidence supports NIPPV to reduce reintubation rates in high-risk populations, particularly COPD, hypercapnia, and heart failure.
2. Weaning BPAP after extubation should be individualized and clinically guided.
3. S/T mode ensures backup breaths when spontaneous effort is reduced.
4. This patient had responded to therapy and was ready for liberation; hence tracheostomy was inappropriate.
5. Acceptable oxygenation should not delay extubation; apnea in this context was more likely due to obesity hypoventilation syndrome.

#### üè∑Ô∏è Tags
#CriticalCare #COPD #NoninvasiveVentilation #BPAP #Extubation #MechanicalVentilation #ObesityHypoventilation #ICU

#### üìö Reference
Boscolo A, Pettenuzzo T, Sella N, et al. Noninvasive respiratory support after extubation: a systematic review and network meta-analysis. *Eur Respir Rev*. 2023;32. PMID: 37019458 doi:10.1183/16000617.0196-2022

#### üÜî Question ID
CCMCQ24029

#### üïí Last Updated
February 2025

---

#### üìñ Related Text
MKSAP 19: Critical Care Medicine ‚Äî Principles of Critical Care, Comprehensive Support of Critically Ill Patients, Mechanical Ventilatory Support: General Principles, Noninvasive Mechanical Ventilation

---

### üìò Related Text Derivations

#### ‚úÖ True Statements ‚Äî Noninvasive Mechanical Ventilation
1. Two common types of **noninvasive positive-pressure ventilation (PPV)** are **continuous positive airway pressure (CPAP)** and **bilevel positive airway pressure (BPAP)**.
2. **Continuous positive airway pressure (CPAP)** delivers a **constant airway pressure** during both inspiration and expiration.
3. **Bilevel positive airway pressure (BPAP)** delivers a **higher pressure during inspiration** than expiration, providing **inspiratory support** and **increased tidal volume**.
4. Some **BPAP devices** can be programmed with a **minimum respiration rate** using the **spontaneous/timed (S/T) mode**.
5. **Average volume-assured pressure support (AVAPS)** integrates features of **volume-controlled** and **pressure-controlled** ventilation and may be **better tolerated** than BPAP by some patients.
6. Evidence supports use of **noninvasive PPV** for **acute COPD exacerbation**, **cardiogenic pulmonary edema**, **neuromuscular disease**, and **obesity hypoventilation syndrome**.
7. **Noninvasive PPV** is indicated for patients being **extubated at high risk for reintubation**, such as those **older than age 65 years** or with **heart failure** or **COPD**.
8. **Late application** of noninvasive PPV when indicated is associated with **increased intubation needs** and **worse outcomes**.
9. **Delaying intubation** when needed, or excessive **tidal volumes** from noninvasive PPV, can result in **patient harm**.
10. Complications of noninvasive PPV include **mucosal dryness**, **nasal congestion**, **facial erosions**, **gastric insufflation**, and, rarely, **pulmonary barotrauma**.
11. Contraindications to noninvasive PPV include **persistent altered mental status**, **increased airway secretions**, **emesis**, **gastric distention**, **airway obstruction**, **recent esophageal surgery**, **cardiac arrest**, **impaired cough reflex or swallowing**, **facial trauma or surgery**, **patient intolerance of the mask**, **anticipated long-term ventilatory support**, and **impaired respiratory drive**.
12. Proper **mask sizing** and **patient adaptation** are essential for successful noninvasive PPV and require **time and coaching**.
13. After initiation of noninvasive PPV, patients should be closely monitored for **tolerance** and **adverse effects**, **ventilatory effectiveness** (tidal volumes and respiration rate), and **clinical improvement** (**blood pH**, **respiration rate**, **oxygen saturation**, **mental status**).

#### üí¨ Extra
3. BPAP‚Äôs inspiratory boost supports ventilation more effectively than CPAP in hypercapnic conditions.
5. AVAPS can auto-adjust to maintain a set tidal volume, improving comfort and synchrony.
8. Timing is critical: early initiation prevents deterioration.
10. Skin breakdown from mask pressure is a frequent complication requiring monitoring.
11. Contraindications ensure safe patient selection to avoid aspiration or failed airway protection.

#### üè∑Ô∏è Tags
#CriticalCare #NoninvasiveVentilation #CPAP #BPAP #AVAPS #ICU #Extubation #Contraindications #VentilationComplications

---

#### üóæ Supplemental Tables

<table>
  <caption><strong>Modes of Noninvasive Positive-Pressure Ventilation</strong></caption>
  <thead>
    <tr>
      <th>Mode</th>
      <th>Function</th>
      <th>Physiologic Effects</th>
      <th>Indications</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>CPAP</td>
      <td>Applies and maintains a constant airway pressure throughout the respiratory cycle</td>
      <td>Maintains patent airway in the setting of obstructive sleep apnea; increases functional residual capacity; increases mean airway pressure</td>
      <td>Obstructive sleep apnea; pulmonary edema; excessive dynamic airway collapse; postextubation in high-risk patients to prevent respiratory failure</td>
    </tr>
    <tr>
      <td>BPAP</td>
      <td>Applies two different levels of airway pressure: IPAP and EPAP</td>
      <td>Same as CPAP but also decreases work of breathing and augments tidal volume</td>
      <td>COPD exacerbation; obesity hypoventilation syndrome; neuromuscular diseases; postextubation in high-risk patients to prevent respiratory failure; time-limited trial in selected ‚Äúdo not intubate‚Äù patients with clear goals of care</td>
    </tr>
    <tr>
      <td>BPAP with S/T mode</td>
      <td>BPAP with a minimum set respiration rate</td>
      <td>In case of central apnea, continues to deliver breaths</td>
      <td>Hypoventilation; central apneas</td>
    </tr>
    <tr>
      <td>AVAPS</td>
      <td>Maximum and minimum IPAP along with a target tidal volume</td>
      <td>Ensures delivery of preset tidal volume to maintain adequate minute ventilation</td>
      <td>Hypoventilation; central apneas; COPD exacerbation</td>
    </tr>
  </tbody>
</table>
<p><em>
AVAPS = average volume‚Äëassured pressure support; BPAP = bilevel positive airway pressure; CPAP = continuous positive airway pressure; EPAP = expiratory positive airway pressure; IPAP = inspiratory positive airway pressure; S/T = spontaneous/timed.
</em></p>
<p><em>
Data from Rochwerg B, Brochard L, Elliott MW, et al. Official ERS/ATS clinical practice guidelines: noninvasive ventilation for acute respiratory failure. <em>Eur Respir J.</em> 2017;50. PMID: 28860265 doi:10.1183/13993003.02426-2016.
</em></p>

#### ‚úÖ True Statements (from Table: Modes of Noninvasive Positive-Pressure Ventilation)
1. **Continuous positive airway pressure (CPAP)** applies a **constant airway pressure** throughout the respiratory cycle and **increases functional residual capacity** and **mean airway pressure**.
2. **Bilevel positive airway pressure (BPAP)** uses **inspiratory positive airway pressure (IPAP)** and **expiratory positive airway pressure (EPAP)** and **decreases work of breathing** while **augmenting tidal volume**.
3. **BPAP in spontaneous/timed (S/T) mode** provides a **minimum set respiration rate** that **continues breaths during central apnea**.
4. **Average volume‚Äëassured pressure support (AVAPS)** targets a **preset tidal volume** to maintain **adequate minute ventilation**.
5. **Postextubation in high‚Äërisk patients** is an **indication** for both **CPAP** and **BPAP** to prevent **respiratory failure**.
6. **Time‚Äëlimited BPAP trials** can be considered in selected **‚Äúdo not intubate‚Äù** patients **with clear goals of care**.

